Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gleason

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Metal impurities cause false positives in high-throughput screening campaignsJohannes C Hermann, Yingsi Chen, Charles Wartchow, et al.
Blood|March 22, 2014
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targetsMichelle K Gleason, Julie A Ross, Erica D Warlick, et al.
Nature Communications|October 10, 2020
Toward three-dimensional hybrid inorganic/organic optoelectronics based on GaN/oCVD-PEDOT structuresLinus Krieg, Florian Meierhofer, Sascha Gorny, et al.
Molecular Carcinogenesis|July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanismBrianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Journal of Medicinal Chemistry|November 15, 2008
Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, Seth F Harris, Seth F Arora, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Metal impurities cause false positives in high-throughput screening campaignsJohannes C Hermann, Yingsi Chen, Charles Wartchow, et al.
Blood|March 22, 2014
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targetsMichelle K Gleason, Julie A Ross, Erica D Warlick, et al.
Nature Communications|October 10, 2020
Toward three-dimensional hybrid inorganic/organic optoelectronics based on GaN/oCVD-PEDOT structuresLinus Krieg, Florian Meierhofer, Sascha Gorny, et al.
Molecular Carcinogenesis|July 4, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanismBrianna L Hill, Alyssa N Calder, Joseph P Flemming, et al.
Journal of Medicinal Chemistry|November 15, 2008
Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, Seth F Harris, Seth F Arora, et al.
Pageof 15